Al-Maidan Clinic for Oral Health Services Company K.S.C.P. (KWSE:MIDAN)
Kuwait · Delayed Price · Currency is KWD 0.8250
0.00 (0.00%)
At close: Oct 28, 2026
KWSE:MIDAN Ratios and Metrics
Market cap in millions KWD. Fiscal year is April - March.
Millions KWD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 167 | 168 | 161 | 93 | 148 | 154 | |
Market Cap Growth | -6.88% | 4.14% | 74.02% | -37.16% | -3.99% | -50.40% |
Enterprise Value | 117 | 119 | 112 | 45 | 112 | 121 |
Last Close Price | 0.82 | 0.76 | 0.71 | 0.40 | 0.64 | 0.60 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.69 | 17.66 | 17.42 | 7.85 | 12.12 | 14.96 |
PS Ratio | 2.64 | 2.66 | 2.24 | 1.22 | 2.03 | 2.17 |
PB Ratio | 1.73 | 1.88 | 1.83 | 1.29 | 2.35 | 2.83 |
P/TBV Ratio | 1.74 | 1.88 | 1.83 | 1.30 | 2.35 | 2.83 |
P/FCF Ratio | 24.41 | 29.49 | 23.04 | 7.38 | 10.84 | 7.71 |
P/OCF Ratio | 12.87 | 14.27 | 18.94 | 6.43 | 9.73 | 7.19 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.85 | 1.89 | 1.55 | 0.60 | 1.54 | 1.71 |
EV/EBITDA Ratio | 10.10 | 13.06 | 13.31 | 3.84 | 7.64 | 8.18 |
EV/EBIT Ratio | 13.57 | 17.63 | 18.22 | 4.63 | 8.68 | 9.20 |
EV/FCF Ratio | 17.16 | 20.90 | 15.92 | 3.61 | 8.22 | 6.09 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.04 | 0.05 | 0.03 |
Debt / EBITDA Ratio | 0.14 | 0.17 | 0.19 | 0.20 | 0.19 | 0.11 |
Debt / FCF Ratio | 0.21 | 0.28 | 0.25 | 0.20 | 0.22 | 0.08 |
Net Debt / Equity Ratio | -0.52 | -0.51 | -0.58 | -0.64 | -0.61 | -0.60 |
Net Debt / EBITDA Ratio | -4.90 | -5.02 | -6.16 | -3.88 | -2.62 | -2.18 |
Net Debt / FCF Ratio | -7.26 | -8.03 | -7.37 | -3.65 | -2.82 | -1.62 |
Asset Turnover | 0.47 | 0.50 | 0.62 | 0.75 | 0.82 | 0.92 |
Inventory Turnover | 14.91 | 15.58 | 19.70 | 20.22 | 18.76 | 18.96 |
Quick Ratio | 2.61 | 2.51 | 2.61 | 2.68 | 2.47 | 2.38 |
Current Ratio | 2.72 | 2.62 | 2.70 | 2.78 | 2.57 | 2.50 |
Return on Equity (ROE) | 11.44% | 10.71% | 11.59% | 17.57% | 20.78% | 20.51% |
Return on Assets (ROA) | 3.58% | 3.33% | 3.28% | 6.09% | 9.04% | 10.70% |
Return on Invested Capital (ROIC) | 16.94% | 16.56% | 19.30% | 38.58% | 55.01% | 55.33% |
Return on Capital Employed (ROCE) | 7.70% | 7.20% | 6.60% | 12.90% | 19.30% | 22.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 6.37% | 5.66% | 5.74% | 12.74% | 8.25% | 6.69% |
FCF Yield | 4.10% | 3.39% | 4.34% | 13.56% | 9.22% | 12.97% |
Dividend Yield | 2.42% | 2.41% | 1.88% | 2.18% | 0.77% | - |
Payout Ratio | 28.47% | 31.88% | 21.80% | 9.46% | 0.03% | 24.18% |
Buyback Yield / Dilution | - | - | 1.88% | 7.81% | 0.50% | - |
Total Shareholder Return | 2.42% | 2.41% | 3.76% | 9.99% | 1.27% | - |